Healthcare News

Déclaration de transactions sur actions propres Paris, France (8 avril 2025, 18h15) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que...

Disclosure of transactions in own shares Paris, France (April 8, 2025 - 6:15 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2024,...

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 8 April 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a...

   Ipsen publie sonDocument d’enregistrement universel 2024 PARIS, FRANCE, 8 avril 2025 - Ipsen (Euronext : IPN ; ADR : IPSEY) annonce aujourd’hui que son Document d’enregistrement universel 2024 a...

    Ipsen publishes its 2024 Universal Registration Document PARIS, FRANCE, 8 April 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the filing of its 2024 Universal Registration...

CVN293 was generally well-tolerated in healthy volunteers with evidence of robust brain penetration, supporting utility of KCNK13 inhibitors for neurodegenerative diseases characterized by...

Neurona Therapeutics Presents Positive Clinical Data Update from NRTX-1001 Cell Therapy Trial in Drug-resistant Epilepsy at American Academy of Neurology A

Cosmos Health launches Sky Premium Life in Albania with Pharma Cell as distributor and secures an initial annual order valued at $300,000.

NASHUA, N.H., April 08, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically...

AscellaHealth Highlights Rare Disease Capabilities and End-to-End Specialty Pharmaceutical Solutions at World Orphan Drug Congress USA 2025